FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Topiramate from Glenmark Pharmaceuticals, authorizing an update or expansion of its labeling/approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)